USD10
DNLI acciones
Acerca de Denali TherapeuticsDenali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
USD10
DNLI acciones
Acerca de Denali TherapeuticsDenali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
23 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
3227,79 M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
10,57 US$
ALTO (1Y)
23,77 US$
BAJO (24H)
20,07 US$
Alza (24H)
20,37 US$
Volumen (24 h)
3,72 mil US$
99,91 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | No hay suficientes datos | No hay suficientes datos |
1 día | 20,17 US$ | |
1 semana | 20,75 US$ | |
1 mes | 20,57 US$ | |
1 año | 14,76 US$ |